ERO1A and gastric cancer: These findings were consistent with several previous studies that overexpression of ERO1L was also observed in gastric cancer (Zhou et al., 2017), oral squamous cell carcinoma (Li, Li, Jiang, Chen, & Gan, 2020) and lung adenocarcinoma (Hsu et al., 2016).